TNF and psoriatic arthritis: Some studies suggest that the tumor necrosis factor alpha component (TNFα) may be considered to be the principal biomarker for PsA diagnosis since treatment with agents that decrease the levels of the TNF are beneficial for psoriatic arthritis patients [95,97,98].